The male god of magic capital

Chapter 150 151 Debt repayment, all 5 million Hong Kong dollars invested!
At 5 o'clock in the afternoon, Luo Cheng was drinking coffee in the office, and his eyes continued to focus on Hong Kong stocks. Now the family foundation's Hong Kong stock account has 10 billion Hong Kong dollars, so he can't be idle. In the end to operate that stock.

In fact, it is not so easy to double the account after the fund exceeds [-] million. After all, it is easy to double the stock price of a company with a small market value, but the transaction volume is small. After the account fund exceeds [-] million, it is difficult to operate a company with a small market value. It is not easy to enter and exit.

The stocks of large companies are easy to enter and exit, and the trading volume is also large, but the increase is limited. After all, companies with a market value of tens of billions or hundreds of billions are basically low in the industry. fundamentals, or major positive news, so it is difficult for a company with a large market capitalization to double its share price.

Large funds can only operate the stocks of large companies, and a profit of more than 20% at a time is very good.

Previously, the family foundation had 2.5 million Hong Kong dollars in its Hong Kong stock account. Thanks to the surge of Innovent Biotech, its net worth has quadrupled. Not bad.

Now that the Hong Kong stock account has reached the level of 10 billion, it is even more difficult to operate. Many companies' stocks are not fancy to Luo Cheng because they are not easy to operate.

Until 8 o'clock in the evening, Luo Cheng chose Fuxing Medical, which is listed on the Hong Kong stock market. This Fuxing Medical is listed on the A-share and Hong Kong stock at the same time, and it is a medical giant listed on the two places.

And this time, Chengtian Private Equity Fund also intends to operate the A-share shares of Fuxing Medicine, and the family foundation also intends to operate Hong Kong shares of Fuxing Medicine.

The total share capital of Fuxing Medicine in A shares is 25 billion shares, the stock price is 60 yuan per share, the market value is 1500 billion yuan, and the daily trading volume is very large.

As for the Hong Kong stock market, Fuxing Pharmaceutical only issued 6 million Hong Kong shares, and the stock price was HK$18 per share. The Hong Kong stock market value was only 108 billion, and the daily trading volume was not high.

It is no problem for Chengtian Private Equity Fund to operate A-share Fuxing Medicine with a full position of 100 billion yuan, but it is not the time yet. Luo Cheng has to wait for the stock price to fall to 50 yuan a share before entering the market.

In the Hong Kong stock market, it is difficult for the Roche Family Foundation to operate Fuxing Medicine, because the transaction volume it says is not high. The Roche Family Foundation’s Hong Kong stock account has 10 billion Hong Kong dollars. It is not easy to enter and exit the market. 10 billion funds are too much , accounting for nearly 10% of the market value.

With such a large amount of funds entering the market, there will not be so many buying orders for Luo Cheng to quickly sell at high prices.

Moreover, if Luo Cheng raises Fuxing Pharmaceutical's stock price too high on the Hong Kong stock market, if the increase is much higher than that of the A-share Fuxing Pharmaceutical, then it will be easy to be targeted by traders from other international financial institutions. Luo Cheng is sucking blood, or his status is disgusting to Luo Cheng.

After all, when the amount of funds is large, there will be a lot of small hot money, and the rat warehouses of large retail investors.

Luo Cheng used to be a small retail investor, and he also set up a mouse warehouse in the same way when he was a small hot money. Fang Xinyu, Li Guanfeng, Zhang Zhihan, Xiao Xinyi, Liu Canghai and others were disgusted.

For the main funds and the big hot money, what they hate the most is someone setting up a mouse warehouse, because after the big hot money and the main money rise, these ghostly mouse warehouses will ship ahead of time, which can be said to be something for nothing, stealing the main money, The money of the big hot money is still openly stolen!

And there is nothing to do with them.

After thinking about it, Luo Cheng doesn't plan to let the Luo Family Foundation operate with a full position this time, because it is not easy to operate with 10 billion funds.

For example, if 10 billion funds enter the market, only 40% of the profit can be made, and 4 million is not easy to operate.

And if 5 million funds can make a profit of 80%, 4 million is easy to operate, and the 5 million funds only account for less than 5% of its Hong Kong stock market value, and can be cleared and run away at any time.

Immediately, Luo Cheng withdrew 5 million Hong Kong dollars to Hongkong Citibank, thinking that his father Luo Ze still owed 7 million Hong Kong dollars to the Bank of East Asia, and 5 million Hong Kong dollars to Dah Sing Bank. Before that, Huang Hanxing urged Luo Cheng.

There was nowhere to go for the 5 million Hong Kong dollars for the time being, so Luo Cheng immediately helped his father Luo Ze repay the 5 million Hong Kong dollars debt of Dah Sing Bank!

Huang Hanxing: "Boss Luo is really fast, can't it be borrowed Hong Kong dollars?"

On Sunday, he urged Luo Cheng to repay the 5 million Hong Kong dollars, but Luo Cheng refused. He thought he would have to wait for a while, but he did not expect to repay the 5 million Hong Kong dollars on Monday.

Luo Cheng: "Hehe, 5 million Hong Kong dollars is just a small change, do I still need to borrow it?"

Huang Hanxing: "Mr. Luo, have you made money in the Xiangjiang stock market? Otherwise, you won't be able to spend 5 million Hong Kong dollars so quickly."

He knows that Luo Cheng's assets are stored in the stock of Chengtian Holding Company in the form of stocks, occupying 75% of the shares, worth more than 90 billion. If Luo Cheng doesn't cash out the stocks, he can't get 5 million Hong Kong dollars. It should be Luo Cheng's Overseas family funds have made money in the Xiangjiang stock market.

The debt of 5 million Hong Kong dollars was repaid to Dah Sing Bank through Hong Kong Citibank. Obviously, Luo Cheng made a lot of money in the Hong Kong stock market.

Luo Cheng smiled and said: "Boss Huang really hit the mark, he just made some small money."

Huang Hanxing: "Boss Luo likes stocks in the medical industry very much. Today, Innovent Biologics has skyrocketed and plummeted. You must have cleared your position in Innovent Biotech."

Luo Cheng: "Boss Huang hit the mark again, hehe, that's right, I made 7.5 million Hong Kong dollars on Cinda Biology, and I just cleared the warehouse this afternoon."

Huang Hanxing was immediately envious: "I didn't expect that Cinda Biological's bull stock would be caught by Mr. Luo."

Then he continued: "Henry Cizek from Jardine Fund also told me today that someone liquidated the stock of Innovent Biological in front of him in advance, which made his operation very difficult. It turned out that Mr. Luo was liquidating the stock behind it!"

Luo Cheng: "Hehe, that's really a pity."

The Jardine Fund is a fund of the Hong Kong Jardine Consortium, and Henry Cizek is quite famous in the international financial center of Hong Kong.

Unexpectedly, when Luo Cheng liquidated his position, Luo Cheng was tricked. After all, Luo Cheng liquidated his position twice when the stock price of Cinda Biotech reached HK$79 per share. The two operations totaled more than 15 billion worth of stocks. It was in front of the Jardine Fund, Henry Cizek could not operate smoothly.

Huang Hanxing: "Mr. Luo, be careful. Your family foundation may be targeted by Jardine Fund and Lion Fund. Haha, I wish you success in the Xiangjiang stock market."

Behind the Lion Fund and the Jardine Fund are the Shenzhen Nuoan Group and the Xiangjiang Jardine Consortium. Luo Cheng had a festive relationship with the two funds when he was on Opconvision before.

At that time, Lion Fund and Jardine Fund planned to oust Tao Jie, the founder of Opcon, and had planned for a long time. Seeing that success was imminent, Luo Cheng indirectly helped Tao Jie stabilize his position in Opcon, allowing the two funds Already very upset.

Now it is normal to be targeted by two funds in the Xiangjiang stock market.

After finishing the phone call, Luo Cheng shook his head and said nonchalantly, "Focus on my family fund. I'm not a big fund. It's only 5 million Hong Kong dollars. Come if you have the money."

The next day, Tuesday, January 1, the Hong Kong stock market opened,

Luo Cheng started to buy Fuxing Pharmaceutical stocks in Hong Kong stocks. The 5 million funds entered the market slowly, because the trading volume of Fuxing Pharmaceutical's stock price is not large, so it needs to accumulate slowly.

He first bought 500 million shares, and the stock price of Fuxing Medicine rushed from 18 Hong Kong dollars per share to 22 Hong Kong dollars per share.

The increase of 22.22% immediately attracted attention.

Lion Fund and Jardine Fund knew that the God of Finance in Shanghai liked stocks in the medical sector, so they immediately followed them.

Lion Fund and Jardine Fund have always been ruthless towards Fuxing Pharmaceutical Company because Fuxing Pharmaceutical, a subsidiary of Fuxing Group, supported Tao Jie before, which interfered with their control of Opcon. Fuxing Pharmaceutical sold a lot of shares, bringing down the share price of Fuxing Pharmaceutical, which increased the financing cost of Fuxing Pharmaceutical. Originally, Fuxing Pharmaceutical planned to raise 1 million shares. The stock price was smashed to 70 yuan a share. If 1 million shares were raised, only 70 billion yuan could be raised.

Currently Lion Fund and Jardine Fund both hold a lot of short positions in the Hong Kong stocks of Fuxing Medicine. Seeing that the stock price has risen, their traders began to short, suppressing the Hong Kong stock price of Fuxing Medicine to 20 Hong Kong dollars a share.

When Luo Cheng saw that he had the funds to suppress Fuxing Pharmaceutical's stock, he didn't want to waste time with them.

Immediately, they started buying in large sums. Since they wanted to suppress them, they just asked Luo Cheng to buy.

Luo Cheng bought another 250 million shares, this time raising the stock price again to 22 Hong Kong dollars per share. share.

In the afternoon, the stock price continued to fall and fell to the 18th position. Luo Cheng bought 250 million shares again, raising the stock price to 20 Hong Kong dollars per share.

In this regard, I bought 1000 million shares, and the average price of opening a position was 20 Hong Kong dollars per share, which has already cost 2 million Hong Kong dollars.

In the evening, Daxin Fund Huang Hanxing called again and said, "Mr. Luo, a friend of mine holds 1500 million Hong Kong shares of Fuxing Medicine. Are you interested in following?"

Luo Cheng: "Who is the other party?"

Huang Hanxing said, "It's Swire Securities!"

Swire Securities is a securities company under the Swire consortium of Hong Kong. It holds 1500 million shares of Fuxing Medicine on the Hong Kong stock market. The purchase cost is 20 Hong Kong dollars per share. It was bought 5 years ago. I have been holding on to the stock, and now I have paid back my capital, and I plan to sell it.

Luo Cheng immediately decided to proceed, and said, "Mr. Huang, I will buy it at the market price."

"Okay, Mr. Luo!" Huang Hanxing was very excited, thinking that Luo Cheng must be a high-ranking successor. He is not optimistic about the stock price of Fuxing Medicine. Now Fuxing Medicine's business in Xiangjiang is facing Shenzhen Nuoan Group and Xiangjiang Yi It will be a matter of time before the stock price falls back to 14 Hong Kong dollars per share due to commercial retaliation from the medical group under the consortium.

Later, Luo Cheng called the Luo Family Foundation Office in Xiangjiang, got a lawyer to sign the equity transfer agreement, and paid 3 million to Swire Securities.

In this regard, 5 million Hong Kong dollars were all invested in the Hong Kong stock market of Fuxing Medicine.

(End of this chapter)